Wu Yu-Jie, Wei Xin, Xiao Man-Yi, Xiong Wei
Department of Ophthalmology and Eye Disease Research Center, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China.
Int J Ophthalmol. 2016 Jun 18;9(6):869-75. doi: 10.18240/ijo.2016.06.14. eCollection 2016.
To evaluate the efficacy and safety of orbital decomposition (OD) surgery in combination with horse chestnut seed extract (HCSE), as compared to OD alone, in patients with thyroid-associated ophthalmopathy (TAO).
Sixty-two orbits from 62 TAO patients were randomly assigned to OD or OD+HCSE at 1:1 ratio (31 received OD alone, 31 received OD+HCSE). Forty-two orbits from 21 healthy subjects were used as controls. Complete ophthalmic examination and color Doppler flow imaging (CDFI) were performed before surgery and 3mo post-surgery on all 62 orbits from the TAO patients. CDFI were also performed on the 42 control orbits. The effect of OD+HCSE and OD alone on TAO orbits was compared on several endpoints, including superior ophthalmic vein blood flow (SOVBF) parameters, subjective assessment, soft tissue involvement, lid retraction, diplopia, eye movement restriction, degree of exophthalmos, and intraocular pressure. The control orbits were used as reference for the SOVBF parameters.
OD surgery with or without HCSE improved SOVBF, symptoms and soft tissue involvement, decreased degree of exophthalmos and intraocular pressure in orbits of TAO patients. The OD+HCSE combination led to significantly better improvement of SOVBF than OD alone. The differences between the reductions of SOVBF in the two groups are 1.26 cm/s in max-volecity and 0.52 cm/s in min-volecity (P<0.0001).
SOVBF is significantly reduced in the orbits affected with TAO, indicating that congestion may be an important factor contributing to TAO pathogenesis. OD surgery improves the SOVBF, and combination of HCSE medication and OD surgery further improved venous return than OD surgery alone.
评估眼眶减压术(OD)联合七叶树籽提取物(HCSE)治疗甲状腺相关眼病(TAO)患者的疗效和安全性,并与单纯眼眶减压术进行比较。
将62例TAO患者的62只眼眶按1:1比例随机分为OD组或OD + HCSE组(31例接受单纯OD治疗,31例接受OD + HCSE治疗)。将21例健康受试者的42只眼眶作为对照。对TAO患者的所有62只眼眶在手术前和手术后3个月进行全面的眼科检查和彩色多普勒血流成像(CDFI)。对42只对照眼眶也进行CDFI检查。比较OD + HCSE组和单纯OD组在几个终点指标上对TAO眼眶的影响,包括眼上静脉血流(SOVBF)参数、主观评估、软组织受累情况、眼睑退缩、复视、眼球运动受限、眼球突出程度和眼压。将对照眼眶的SOVBF参数作为参考。
无论是否联合HCSE,眼眶减压术均改善了TAO患者眼眶的SOVBF、症状和软组织受累情况,降低了眼球突出程度和眼压。OD + HCSE联合治疗导致SOVBF的改善明显优于单纯眼眶减压术。两组SOVBF降低值的差异为最大流速1.26 cm/s,最小流速0.52 cm/s(P < 0.0001)。
TAO受累眼眶的SOVBF显著降低,表明充血可能是TAO发病机制的一个重要因素。眼眶减压术可改善SOVBF,HCSE药物与眼眶减压术联合应用比单纯眼眶减压术更能改善静脉回流。